Discovery to Market
Discovery to Market articles place a focus on the commercial side of research and how scientific discoveries can impact the public.
Insulin: From Inspiring Discovery to Deadly Expense
Half a billion people today suffer from diabetes, a disease that causes high blood glucose levels. Although no cure exists as yet, the remarkable discovery and subsequent development of insulin injections have allowed millions of [...]
Graphene May Be a Wonder Material, But Don’t Hold Your Breath
The discovery of graphene back in 2004 brought about the prospect of exciting new possibilities. Light as a feather yet stronger than Kevlar, many believed graphene to be a wonder material, capable of changing the [...]
Evaluating Modafinil as a Smart Drug (20 Years of Data)
Modafinil (Provigil) first entered the U.S. markets in 1998 after FDA approval. Although it was initially intended to treat narcolepsy and related sleep disorders, it quickly garnered a reputation as an off-label ‘smart drug’. We [...]
Coronavirus Vaccine Development—Look Before You Leap
Nothing short of a medical miracle, coronavirus vaccines may be on the verge of being available to the public. Just months after its rapid spread throughout the world, scientists are making great strides toward delivering [...]
How Methamphetamine Fueled Blitzkrieg and Beyond
The initial success of Nazi Germany in World War II is largely attributed to the strategy of Blitzkrieg: quick, surprise maneuvers through enemy territory that gives opponents little time to react. This, however, placed a [...]
Biologic Drugs—The Future of Medicine
Biologics is the buzzword within drug discovery these days. The days of small molecule therapeutics are numbered, with pharmaceutical companies and research institutes shifting their focus to large molecule ‘biologics’. Despite being extremely complex to [...]
